| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 33.850 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.100 |
| Total Income - EUR | - | 33.850 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.107 |
| Total Expenses - EUR | - | 11.089 | 1.929 | 1.824 | 536 | 1.016 | 533 | 669 | 144 | 1.809 |
| Gross Profit/Loss - EUR | - | 22.761 | -1.929 | -1.824 | -536 | -1.016 | -533 | -669 | -144 | 7.298 |
| Net Profit/Loss - EUR | - | 21.746 | -1.929 | -1.824 | -536 | -1.016 | -533 | -669 | -144 | 5.988 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dywa Medical Solutions Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 31.627 | 19.766 | 2.358 | 1.931 | 1.895 | 1.853 | 1.858 | 1.853 | 9.075 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 31.543 | 16.544 | 2.267 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 84 | 3.222 | 90 | 1.931 | 1.895 | 1.853 | 1.858 | 1.853 | 9.075 |
| Shareholders Funds | - | 21.790 | -1.885 | -3.675 | -4.140 | -5.077 | -5.498 | -6.184 | -6.309 | -285 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 9.837 | 21.650 | 6.032 | 6.071 | 6.972 | 7.351 | 8.043 | 8.162 | 9.361 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8299 - 8299" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Dywa Medical Solutions Srl